Morris S. Gold

2.1k total citations
46 papers, 1.5k citations indexed

About

Morris S. Gold is a scholar working on Physiology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Morris S. Gold has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 16 papers in Pharmacology and 13 papers in Psychiatry and Mental health. Recurrent topics in Morris S. Gold's work include Inflammatory mediators and NSAID effects (16 papers), Obstructive Sleep Apnea Research (10 papers) and Osteoarthritis Treatment and Mechanisms (10 papers). Morris S. Gold is often cited by papers focused on Inflammatory mediators and NSAID effects (16 papers), Obstructive Sleep Apnea Research (10 papers) and Osteoarthritis Treatment and Mechanisms (10 papers). Morris S. Gold collaborates with scholars based in United States, Switzerland and Germany. Morris S. Gold's co-authors include Avram R. Gold, Roy D. Altman, Jean‐Luc Kienzler, Joan E. Broderick, H. Richard Barthel, Mohammad M. Amin, Herbert S. B. Baraf, CD Buckner, John A. Hansen and John Nemunaitis and has published in prestigious journals such as New England Journal of Medicine, CHEST Journal and Medicine & Science in Sports & Exercise.

In The Last Decade

Morris S. Gold

44 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morris S. Gold United States 20 477 394 299 250 239 46 1.5k
Magdalena Olszanecka‐Glinianowicz Poland 27 723 1.5× 187 0.5× 110 0.4× 67 0.3× 27 0.1× 195 2.8k
Fahrı Bayram Türkiye 34 302 0.6× 131 0.3× 206 0.7× 116 0.5× 26 0.1× 149 3.0k
Antonino Catalano Italy 25 253 0.5× 60 0.2× 390 1.3× 82 0.3× 93 0.4× 108 2.1k
G. Dobos Germany 15 183 0.4× 87 0.2× 102 0.3× 58 0.2× 81 0.3× 60 1.0k
Tomi S. Mikkola Finland 29 341 0.7× 68 0.2× 235 0.8× 281 1.1× 19 0.1× 147 3.1k
Neeta Parimi United States 25 234 0.5× 89 0.2× 189 0.6× 303 1.2× 12 0.1× 58 1.8k
Reina Armamento‐Villareal United States 31 1.6k 3.3× 195 0.5× 675 2.3× 113 0.5× 23 0.1× 82 3.7k
M. Pertovaara Finland 22 499 1.0× 68 0.2× 88 0.3× 236 0.9× 22 0.1× 34 1.5k
Valérie Wolff France 21 82 0.2× 473 1.2× 68 0.2× 160 0.6× 44 0.2× 75 1.6k
Georgios K. Dimitriadis United Kingdom 22 364 0.8× 113 0.3× 156 0.5× 44 0.2× 20 0.1× 100 1.7k

Countries citing papers authored by Morris S. Gold

Since Specialization
Citations

This map shows the geographic impact of Morris S. Gold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morris S. Gold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morris S. Gold more than expected).

Fields of papers citing papers by Morris S. Gold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morris S. Gold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morris S. Gold. The network helps show where Morris S. Gold may publish in the future.

Co-authorship network of co-authors of Morris S. Gold

This figure shows the co-authorship network connecting the top 25 collaborators of Morris S. Gold. A scholar is included among the top collaborators of Morris S. Gold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morris S. Gold. Morris S. Gold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stoohs, Riccardo & Morris S. Gold. (2022). Symptoms of sleep disordered breathing: Association with the apnea-hypopnea index and somatic arousal. Sleep Medicine. 101. 350–356. 2 indexed citations
2.
3.
Gold, Avram R., Joan E. Broderick, Morris S. Gold, & Mohammad M. Amin. (2013). A comparison of inspiratory airflow dynamics during sleep between upper airway resistance syndrome patients and healthy controls. Sleep And Breathing. 17(4). 1169–1178. 3 indexed citations
4.
Petruschke, Richard A., et al.. (2011). Safety of Topical Diclofenac Sodium 1% Gel: A Pooled Analysis of Randomized Controlled Trials. Journal of the American Medical Directors Association. 12(3). B24–B24. 1 indexed citations
5.
Barthel, H. Richard, et al.. (2010). Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hocanalysis. Arthritis Research & Therapy. 12(1). R7–R7. 44 indexed citations
6.
Baraf, Herbert S. B., Morris S. Gold, Michael B. Clark, & Roy D. Altman. (2010). Safety and Efficacy of Topical Diclofenac Sodium 1% Gel in Knee Osteoarthritis: A Randomized Controlled Trial. The Physician and Sportsmedicine. 38(2). 19–28. 42 indexed citations
7.
Gloth, F. Michael, et al.. (2010). Safety of diclofenac sodium 1% gel for knee osteoarthritis in patients with comorbidities. Journal of Pain. 11(4). S52–S52.
8.
Amin, Mohammad M., Morris S. Gold, Joan E. Broderick, & Avram R. Gold. (2010). The effect of nasal continuous positive airway pressure on the symptoms of Gulf War illness. Sleep And Breathing. 15(3). 579–587. 15 indexed citations
9.
Kienzler, Jean‐Luc, et al.. (2009). Systemic Bioavailability of Topical Diclofenac Sodium Gel 1% Versus Oral Diclofenac Sodium in Healthy Volunteers. The Journal of Clinical Pharmacology. 50(1). 50–61. 113 indexed citations
10.
Barthel, H. Richard, et al.. (2009). Randomized Controlled Trial of Diclofenac Sodium Gel in Knee Osteoarthritis. Seminars in Arthritis and Rheumatism. 39(3). 203–212. 84 indexed citations
11.
O’Hearn, Daniel J., et al.. (2008). Lower extremity edema and pulmonary hypertension in morbidly obese patients with obstructive sleep apnea. Sleep And Breathing. 13(1). 25–34. 13 indexed citations
12.
Gold, Avram R., et al.. (2007). Hypersomnolence, insomnia and the pathophysiology of upper airway resistance syndrome. Sleep Medicine. 9(6). 675–683. 40 indexed citations
13.
Gold, Avram R., et al.. (2004). Inspiratory Airflow Dynamics During Sleep in Women with Fibromyalgia. SLEEP. 27(3). 459–466. 65 indexed citations
14.
Gold, Morris S., et al.. (2003). Analgesic efficacy of low-dose diclofenac versus paracetamol and placebo in postoperative dental pain.. PubMed. 17(3). 237–44. 19 indexed citations
15.
Gold, Avram R., et al.. (2003). The Symptoms and Signs of Upper Airway Resistance Syndrome. CHEST Journal. 123(1). 87–95. 80 indexed citations
16.
Gold, Morris S., et al.. (2003). Low‐dose diclofenac potassium in the treatment of episodic tension‐type headache. European Journal of Pain. 7(2). 155–162. 42 indexed citations
17.
Meltzer, Eli O., Thomas B. Casale, Morris S. Gold, et al.. (2003). Efficacy and safety of clemastine-pseudoephedrine-acetaminophen versus pseudoephedrine-acetaminophen in the treatment of seasonal allergic rhinitis in a 1-day, placebo-controlled park study. Annals of Allergy Asthma & Immunology. 90(1). 79–86. 7 indexed citations
18.
Géhanno, P, et al.. (2003). Lowest Effective Single Dose of Diclofenac for Antipyretic and Analgesic Effects in Acute Febrile Sore Throat. Clinical Drug Investigation. 23(4). 263–271. 28 indexed citations
19.
Gold, Avram R., et al.. (2002). Upper Airway Collapsibility During Sleep in Upper Airway Resistance Syndrome. CHEST Journal. 121(5). 1531–1540. 82 indexed citations
20.
Nemunaitis, John, Jack W. Singer, Philip J. Bierman, et al.. (1991). Recombinant Granulocyte-Macrophage Colony-Stimulating Factor after Autologous Bone Marrow Transplantation for Lymphoid Cancer. New England Journal of Medicine. 324(25). 1773–1778. 398 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalena Olszanecka‐Glinianowicz Breakdown of academic impact, for papers by Fahrı Bayram Breakdown of academic impact, for papers by Antonino Catalano Breakdown of academic impact, for papers by G. Dobos Breakdown of academic impact, for papers by Tomi S. Mikkola Breakdown of academic impact, for papers by Neeta Parimi Breakdown of academic impact, for papers by Reina Armamento‐Villareal Breakdown of academic impact, for papers by M. Pertovaara Breakdown of academic impact, for papers by Valérie Wolff Breakdown of academic impact, for papers by Georgios K. Dimitriadis
Rankless by CCL
2026